Will the Viewing Audience Stay Tuned?

THE INFINITE VOYAGE “Unseen Worlds,” Part 1 of a 12-part, 3-year television series to be shown on PBS and selected commercial stations. Produced by WQED/ Pittsburgh in association with the National Academy of Sciences with funding from Digital Equipment Corp. The latest big, respectable, complicated television series about science is The Infinite Voyage. Its subtitle (and stated organizing principle) is “The Great Adventure of Scientific Exploration and Discovery.” B

Written byTabitha Powledge
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

“Unseen Worlds,” Part 1 of a 12-part,
3-year television series to be shown on
PBS and selected commercial
stations. Produced by WQED/
Pittsburgh in association with the
National Academy of Sciences with
funding from Digital Equipment Corp.

The latest big, respectable, complicated television series about science is The Infinite Voyage. Its subtitle (and stated organizing principle) is “The Great Adventure of Scientific Exploration and Discovery.” But the first installment, just aired on public television and just about to be aired on a dozen large commercial stations, doesn’t really get around to making that point until the end. Then we are shown a bunch of Fermilab physicists whooping it up at the conclusion of a successful experiment, Leon Lederman in their midst declaring, “This is what science is all about.”

For the most part, “Unseen Worlds” comes across as something of a hodgepodge, now briefly attending an autopsy on an ancient ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies